サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1325275

放射性医薬品注射器の世界市場：成長動向と競合の分析（2023年～2029年）

Global Radiopharmaceutical Injector Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
出版日: | 発行: QYResearch | ページ情報: 英文 162 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
放射性医薬品注射器の世界市場：成長動向と競合の分析（2023年～2029年）
出版日: 2023年08月09日
発行: QYResearch
ページ情報: 英文 162 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の放射性医薬品注射器の市場規模は、2022年の2,721万米ドルから2029年までに4,618万米ドルに達し、予測期間（2023年～2029年）にCAGRで7.35%の成長が予測されています。

当レポートでは、世界の放射性医薬品注射器市場について調査分析し、市場規模と予測、地域とセグメントの分析、企業プロファイルなどを提供しています。

目次

第1章 レポートの概要

  • 放射性医薬品注射器の定義
  • 市場：タイプ別
    • 世界の放射性医薬品注射器の市場規模成長率：タイプ別（2018年・2022年・2029年）
    • PET放射性医薬品注射器
    • PET・SPECT放射性医薬品注射器
  • 市場：用途別
    • 世界の放射性医薬品注射器の市場規模成長率：用途別（2018年・2022年・2029年）
    • 病院、診療所
    • 研究開発機関
  • 前提条件と制限
  • 調査目的
  • 考慮された年数

第2章 世界の放射性医薬品注射器の売上

  • 世界の放射性医薬品注射器の収益の推計と予測（2018年～2029年）
  • 世界の放射性医薬品注射器の収益：地域別（2018年・2022年・2029年）
  • 世界の放射性医薬品注射器の収益：地域別
    • 世界の放射性医薬品注射器の収益：地域別（2018年～2023年）
    • 世界の放射性医薬品注射器の収益：地域別（2024年～2029年）
  • 世界の放射性医薬品注射器の販売数量の推計と予測（2018年～2029年）
  • 世界の放射性医薬品注射器の販売数量：地域別（2018年・2022年・2029年）
  • 世界の放射性医薬品注射器の販売数量：地域別
    • 世界の放射性医薬品注射器の販売数量：地域別（2018年～2023年）
    • 世界の放射性医薬品注射器の販売数量：地域別（2024年～2029年）
  • 北米
  • 欧州
  • 日本
  • 中国
  • アジア太平洋（中国と日本を除く）
  • 中東・アフリカ・南米

第3章 世界の生産（生産拠点ベース）

  • 世界の放射性医薬品注射器生産能力（2018年～2029年）
  • 世界の放射性医薬品注射器生産：地域別（2018年・2022年・2029年）
  • 世界の放射性医薬品注射器生産：地域別
    • 世界の放射性医薬品注射器生産実績：地域別（2018年～2023年）
    • 世界の放射性医薬品注射器生産予測：地域別（2024年～2029年）
    • 北米
    • 欧州
    • 日本

第4章 競合：メーカー別

  • 世界の放射性医薬品注射器の販売数量：メーカー別
    • 世界の放射性医薬品注射器の販売数量：メーカー別（2021年～2023年）
    • 世界の放射性医薬品注射器の販売数量シェア：メーカー別（2021年～2023年）
  • 世界の放射性医薬品注射器の収益：メーカー別
    • 世界の放射性医薬品注射器の収益：メーカー別（2021年～2023年）
    • 世界の放射性医薬品注射器の収益シェア：メーカー別（2021年～2023年）
  • 世界の放射性医薬品注射器の販売価格：メーカー別
  • 競合情勢の分析
    • メーカーの市場集中度（CR5）
    • 世界の放射性医薬品注射器の市場シェア：企業タイプ別（Tier 1、Tier 2、Tier 3）
  • 世界の放射性医薬品注射器の主要メーカー、主な市場エリアと本社
  • 世界の放射性医薬品注射器の主要メーカー、提供製品
  • 世界の放射性医薬品注射器の主要メーカー、業界参入日

第5章 推計と予測：タイプ別

  • 世界の放射性医薬品注射器の販売数量：タイプ別
    • 世界の放射性医薬品注射器の販売数量の実績：タイプ別（2018年～2023年）
    • 世界の放射性医薬品注射器の販売数量の予測：タイプ別（2024年～2029年）
    • 世界の放射性医薬品注射器の販売数量の市場シェア：タイプ別（2018年～2029年）
  • 世界の放射性医薬品注射器の収益：タイプ別
    • 世界の放射性医薬品注射器の収益の実績：タイプ別（2018年～2023年）
    • 世界の放射性医薬品注射器の収益の予測：タイプ別（2024年～2029年）
    • 世界の放射性医薬品注射器の収益の市場シェア：タイプ別（2018年～2029年）
  • 世界の放射性医薬品注射器の価格：タイプ別
    • 世界の放射性医薬品注射器の価格：タイプ別（2018年～2023年）
    • 世界の放射性医薬品注射器の価格の予測：タイプ別（2024年～2029年）

第6章 市場規模：用途別

  • 世界の放射性医薬品注射器の販売数量：用途別
    • 世界の放射性医薬品注射器の販売数量の実績：用途別（2018年～2023年）
    • 世界の放射性医薬品注射器の販売数量の予測：用途別（2024年～2029年）
    • 世界の放射性医薬品注射器の販売数量の市場シェア：用途別（2018年～2029年）
  • 世界の放射性医薬品注射器の収益：用途別
    • 世界の放射性医薬品注射器の収益の実績：用途別（2018年～2023年）
    • 世界の放射性医薬品注射器の収益の予測：用途別（2024年～2029年）
    • 世界の放射性医薬品注射器の収益の市場シェア：用途別（2018年～2029年）
  • 世界の放射性医薬品注射器の価格：用途別
    • 世界の放射性医薬品注射器の価格：用途別（2018年～2023年）
    • 世界の放射性医薬品注射器の価格の予測：用途別（2024年～2029年）

第7章 北米

  • 北米の放射性医薬品注射器の売上：企業別
    • 北米の放射性医薬品注射器の販売数量：企業別（2021年～2023年）
    • 北米の放射性医薬品注射器の収益：企業別（2021年～2023年）
  • 北米の放射性医薬品注射器の市場規模：タイプ別
    • 北米の放射性医薬品注射器の販売数量：タイプ別（2018年～2029年）
    • 北米の放射性医薬品注射器の売上シェア：タイプ別（2018年～2029年）
  • 北米の放射性医薬品注射器の市場規模：用途別
    • 北米の放射性医薬品注射器の販売数量：用途別（2018年～2029年）
    • 北米の放射性医薬品注射器の売上シェア：用途別（2018年～2029年）
  • 北米の放射性医薬品注射器の市場規模：国別
    • 北米の放射性医薬品注射器の収益：国別（2018年・2022年・2029年）
    • 北米の放射性医薬品注射器の収益：国別（2018年～2029年）
    • 北米の放射性医薬品注射器の販売数量：国別（2018年～2029年）
    • 米国
    • カナダ
    • メキシコ

第8章 欧州

  • 欧州の放射性医薬品注射器の売上：企業別
    • 欧州の放射性医薬品注射器の販売数量：企業別（2021年～2023年）
    • 欧州の放射性医薬品注射器の収益：企業別（2021年～2023年）
  • 欧州の放射性医薬品注射器の市場規模：タイプ別
    • 欧州の放射性医薬品注射器の売上：タイプ別（2018年～2029年）
    • 欧州の放射性医薬品注射器の売上シェア：タイプ別（2018年～2029年）
  • 欧州の放射性医薬品注射器の市場規模：用途別
    • 欧州の放射性医薬品注射器の販売数量：用途別（2018年～2029年）
    • 欧州の放射性医薬品注射器の売上シェア：用途別（2018年～2029年）
  • 欧州の放射性医薬品注射器の市場規模：国別
    • 欧州の放射性医薬品注射器の収益：国別（2018年・2022年・2029年）
    • 欧州の放射性医薬品注射器の収益：国別（2018年～2029年）
    • 欧州の放射性医薬品注射器の販売数量：国別（2018年～2029年）
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ベネルクス

第9章 中国

  • 中国の放射性医薬品注射器の売上：企業別
    • 中国の放射性医薬品注射器の販売数量：企業別（2021年～2023年）
    • 中国の放射性医薬品注射器の収益：企業別（2021年～2023年）
  • 中国の放射性医薬品注射器の市場規模：タイプ別
    • 中国の放射性医薬品注射器の売上：タイプ別（2018年～2029年）
    • 中国の放射性医薬品注射器の売上シェア：タイプ別（2018年～2029年）
  • 中国の放射性医薬品注射器の市場規模：用途別
    • 中国の放射性医薬品注射器の売上：用途別（2018年～2029年）
    • 中国の放射性医薬品注射器の売上シェア：用途別（2018年～2029年）

第10章 日本

  • 日本の放射性医薬品注射器の売上：企業別
    • 日本の放射性医薬品注射器の販売数量：企業別（2021年～2023年）
    • 日本の放射性医薬品注射器の売上：企業別（2021年～2023年）
  • 日本の放射性医薬品注射器の市場規模：タイプ別
    • 日本の放射性医薬品注射器の売上：タイプ別（2018年～2029年）
    • 日本の放射性医薬品注射器の売上シェア：タイプ別（2018年～2029年）
  • 日本の放射性医薬品注射器の市場規模：用途別
    • 日本の放射性医薬品注射器の売上：用途別（2018年～2029年）
    • 日本の放射性医薬品注射器の売上シェア：用途別（2018年～2029年）

第11章 アジア太平洋（中国と日本を除く）

  • アジア太平洋の放射性医薬品注射器の売上：企業別
    • アジア太平洋の放射性医薬品注射器の販売数量：企業別（2021年～2023年）
    • アジア太平洋の放射性医薬品注射器の収益：企業別（2021年～2023年）
  • アジア太平洋の放射性医薬品注射器の市場規模：タイプ別
    • アジア太平洋の放射性医薬品注射器の売上：タイプ別（2018年～2029年）
    • アジア太平洋の放射性医薬品注射器の売上シェア：タイプ別（2018年～2029年）
  • アジア太平洋の放射性医薬品注射器の市場規模：用途別
    • アジア太平洋の放射性医薬品注射器の売上：用途別（2018年～2029年）
    • アジア太平洋の放射性医薬品注射器の売上シェア：用途別（2018年～2029年）
  • アジア太平洋の放射性医薬品注射器の市場規模：地域別
    • アジア太平洋の放射性医薬品注射器の収益：地域別（2018年・2022年・2029年）
    • アジア太平洋の放射性医薬品注射器の収益：地域別（2018年～2029年）
    • アジア太平洋の放射性医薬品注射器の販売数量：地域別（2018年～2029年）
    • 韓国
    • 東南アジア
    • インド

第12章 中東・アフリカ・南米

  • 中東・アフリカ・南米の放射性医薬品注射器の売上：企業別
    • 中東・アフリカ・南米の放射性医薬品注射器の販売数量：企業別（2021年～2023年）
    • 中東・アフリカ・南米の放射性医薬品注射器の収益：企業別（2021年～2023年）
  • 中東・アフリカ・南米の放射性医薬品注射器の市場規模：タイプ別
    • 中東・アフリカ・南米の放射性医薬品注射器の販売数量：タイプ別（2018年～2029年）
    • 中東・アフリカ・南米の放射性医薬品注射器の売上シェア：タイプ別（2018年～2029年）
  • 中東・アフリカ・南米の放射性医薬品注射器の市場規模：用途別
    • 中東・アフリカ・南米の放射性医薬品注射器の販売数量：用途別（2018年～2029年）
    • 中東・アフリカ・南米の放射性医薬品注射器の売上シェア：用途別（2018年～2029年）
  • 中東・アフリカ・南米の放射性医薬品注射器の市場規模：国別
    • 中東・アフリカ・南米の放射性医薬品注射器の収益：国別（2018年・2022年・2029年）
    • 中東・アフリカ・南米の放射性医薬品注射器の収益：国別（2018年～2029年）
    • 中東・アフリカ・南米の放射性医薬品注射器の販売数量：国別（2018年～2029年）

第13章 企業プロファイル

  • Medrad, Inc. (Bayer)
  • UNIVERSAL GIKEN
  • Comecer
  • Sumitomo Heavy Industries
  • Tema Sinergie
  • Lemer Pax
  • BQSV

第14章 バリューチェーンと販売チャネルの分析

  • 放射性医薬品注射器のバリューチェーン分析
  • 放射性医薬品注射器の主な原材料
    • 主な原材料
    • 原材料の主要サプライヤー
  • 放射性医薬品注射器の生産方式とプロセス
  • 放射性医薬品注射器の販売とマーケティング
    • 放射性医薬品注射器の販売チャネル
    • 放射性医薬品注射器の販売業者
  • 放射性医薬品注射器の顧客

第15章 放射性医薬品注射器の市場力学

  • 放射性医薬品注射器業界の動向
  • 放射性医薬品注射器市場の促進要因
  • 放射性医薬品注射器市場の課題
  • 放射性医薬品注射器市場の抑制要因

第16章 主な調査結果

第17章 付録

図表

List of Tables

  • Table 1. Global Radiopharmaceutical Injector Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of PET and SPECT Radioactive Drugs Injector
  • Table 3. Global Radiopharmaceutical Injector Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 4. Global Radiopharmaceutical Injector Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 5. Global Radiopharmaceutical Injector Revenue by Region (2018-2023) & (US$ Million)
  • Table 6. Global Radiopharmaceutical Injector Revenue Market Share by Region (2018-2023)
  • Table 7. Global Radiopharmaceutical Injector Revenue by Region (2024-2029) & (US$ Million)
  • Table 8. Global Radiopharmaceutical Injector Revenue Market Share by Region (2024-2029)
  • Table 9. Global Radiopharmaceutical Injector Sales Quantity by Region: 2018 VS 2022 VS 2029 (Units)
  • Table 10. Global Radiopharmaceutical Injector Sales Quantity by Region (2018-2023) & (Units)
  • Table 11. Global Radiopharmaceutical Injector Sales Quantity Market Share by Region (2018-2023)
  • Table 12. Global Radiopharmaceutical Injector Sales Quantity by Region (2024-2029) & (Units)
  • Table 13. Global Radiopharmaceutical Injector Sales Quantity Market Share by Region (2024-2029)
  • Table 14. Global Radiopharmaceutical Injector Production Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (Units)
  • Table 15. Global Radiopharmaceutical Injector Production by Region (2018-2023) & (Units)
  • Table 16. Global Radiopharmaceutical Injector Production Market Share by Region (2018-2023)
  • Table 17. Global Radiopharmaceutical Injector Production by Region (2024-2029) & (Units)
  • Table 18. Global Radiopharmaceutical Injector Production Market Share by Region (2024-2029)
  • Table 19. Global Radiopharmaceutical Injector Sales Quantity by Manufacturers (2021-2023) & (Units)
  • Table 20. Global Radiopharmaceutical Injector Sales Quantity Share by Manufacturers (2021-2023)
  • Table 21. Global Radiopharmaceutical Injector Revenue by Manufacturers (2021-2023) & (US$ Million)
  • Table 22. Global Radiopharmaceutical Injector Revenue Share by Manufacturers (2021-2023)
  • Table 23. Global Radiopharmaceutical Injector Price by Manufacturers 2018-2023 (K USD/Unit)
  • Table 24. Global Radiopharmaceutical Injector Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 25. Global Radiopharmaceutical Injector by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Injector as of 2022)
  • Table 26. Global Key Manufacturers of Radiopharmaceutical Injector, Major Market Areas and Headquarters
  • Table 27. Global Key Manufacturers of Radiopharmaceutical Injector, Product Offered
  • Table 28. Global Key Manufacturers of Radiopharmaceutical Injector, Date of Enter into This Industry
  • Table 29. Global Radiopharmaceutical Injector Sales Quantity by Type (2018-2023) & (Units)
  • Table 30. Global Radiopharmaceutical Injector Sales Quantity by Type (2024-2029) & (Units)
  • Table 31. Global Radiopharmaceutical Injector Sales Quantity Share by Type (2018-2023)
  • Table 32. Global Radiopharmaceutical Injector Sales Quantity Share by Type (2024-2029)
  • Table 33. Global Radiopharmaceutical Injector Revenue by Type (2018-2023) & (US$ Million)
  • Table 34. Global Radiopharmaceutical Injector Revenue by Type (2024-2029) & (US$ Million)
  • Table 35. Global Radiopharmaceutical Injector Revenue Share by Type (2018-2023)
  • Table 36. Global Radiopharmaceutical Injector Revenue Share by Type (2024-2029)
  • Table 37. Radiopharmaceutical Injector Price by Type (2018-2023) & (K USD/Unit)
  • Table 38. Global Radiopharmaceutical Injector Price Forecast by Type (2024-2029) & (K USD/Unit)
  • Table 39. Global Radiopharmaceutical Injector Sales Quantity by Application (2018-2023) & (Units)
  • Table 40. Global Radiopharmaceutical Injector Sales Quantity by Application (2024-2029) & (Units)
  • Table 41. Global Radiopharmaceutical Injector Sales Quantity Share by Application (2018-2023)
  • Table 42. Global Radiopharmaceutical Injector Sales Quantity Share by Application (2024-2029)
  • Table 43. Global Radiopharmaceutical Injector Revenue by Application (2018-2023) & (US$ Million)
  • Table 44. Global Radiopharmaceutical Injector Revenue by Application (2024-2029) & (US$ Million)
  • Table 45. Global Radiopharmaceutical Injector Revenue Share by Application (2018-2023)
  • Table 46. Global Radiopharmaceutical Injector Revenue Share by Application (2024-2029)
  • Table 47. Radiopharmaceutical Injector Price by Application (2018-2023) & (K USD/Unit)
  • Table 48. Global Radiopharmaceutical Injector Price Forecast by Application (2024-2029) & (K USD/Unit)
  • Table 49. North America Radiopharmaceutical Injector Sales Quantity by Company (2021-2023) & (Units)
  • Table 50. North America Radiopharmaceutical Injector Sales Quantity Market Share by Company (2021-2023)
  • Table 51. North America Radiopharmaceutical Injector Revenue by Company (2021-2023) & (US$ Million)
  • Table 52. North America Radiopharmaceutical Injector Revenue Market Share by Company (2021-2023)
  • Table 53. North America Radiopharmaceutical Injector Sales Quantity by Type (2018-2023) & (Units)
  • Table 54. North America Radiopharmaceutical Injector Sales Quantity by Type (2024-2029) & (Units)
  • Table 55. North America Radiopharmaceutical Injector Sales Share by Type (2018-2023)
  • Table 56. North America Radiopharmaceutical Injector Sales Share by Type (2024-2029)
  • Table 57. North America Radiopharmaceutical Injector Sales Quantity by Application (2018-2023) & (Units)
  • Table 58. North America Radiopharmaceutical Injector Sales Quantity by Application (2024-2029) & (Units)
  • Table 59. North America Radiopharmaceutical Injector Sales Share by Application (2018-2023) & (US$ Million)
  • Table 60. North America Radiopharmaceutical Injector Sales Share by Application (2024-2029) & (US$ Million)
  • Table 61. North America Radiopharmaceutical Injector Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 62. North America Radiopharmaceutical Injector Revenue by Country (2018-2023) & (US$ Million)
  • Table 63. North America Radiopharmaceutical Injector Revenue by Country (2024-2029) & (US$ Million)
  • Table 64. North America Radiopharmaceutical Injector Sales Quantity by Country (2018-2023) & (Units)
  • Table 65. North America Radiopharmaceutical Injector Sales Quantity by Country (2024-2029) & (Units)
  • Table 66. Europe Radiopharmaceutical Injector Sales Quantity by Company (2021-2023) & (Units)
  • Table 67. Europe Radiopharmaceutical Injector Sales Quantity Market Share by Company (2021-2023)
  • Table 68. Europe Radiopharmaceutical Injector Revenue by Company (2021-2023) & (US$ Million)
  • Table 69. Europe Radiopharmaceutical Injector Revenue Market Share by Company (2021-2023)
  • Table 70. Europe Radiopharmaceutical Injector Sales by Type (2018-2023) & (Units)
  • Table 71. Europe Radiopharmaceutical Injector Sales by Type (2024-2029) & (Units)
  • Table 72. Europe Radiopharmaceutical Injector Sales Share by Type (2018-2023)
  • Table 73. Europe Radiopharmaceutical Injector Sales Share by Type (2024-2029)
  • Table 74. Europe Radiopharmaceutical Injector Sales Quantity by Application (2018-2023) & (Units)
  • Table 75. Europe Radiopharmaceutical Injector Sales Quantity by Application (2024-2029) & (Units)
  • Table 76. Europe Radiopharmaceutical Injector Sales Share by Application (2018-2023) & (US$ Million)
  • Table 77. Europe Radiopharmaceutical Injector Sales Share by Application (2024-2029) & (US$ Million)
  • Table 78. Europe Radiopharmaceutical Injector Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 79. Europe Radiopharmaceutical Injector Revenue by Country (2018-2023) & (US$ Million)
  • Table 80. Europe Radiopharmaceutical Injector Revenue by Country (2024-2029) & (US$ Million)
  • Table 81. Europe Radiopharmaceutical Injector Sales Quantity by Country (2018-2023) & (Units)
  • Table 82. Europe Radiopharmaceutical Injector Sales Quantity by Country (2024-2029) & (Units)
  • Table 83. China Radiopharmaceutical Injector Sales Quantity by Company (2021-2023) & (Units)
  • Table 84. China Radiopharmaceutical Injector Sales Quantity Market Share by Company (2021-2023)
  • Table 85. China Radiopharmaceutical Injector Revenue by Company (2021-2023) & (US$ Million)
  • Table 86. China Radiopharmaceutical Injector Revenue Market Share by Company (2021-2023)
  • Table 87. China Radiopharmaceutical Injector Sales by Type (2018-2023) & (Units)
  • Table 88. China Radiopharmaceutical Injector Sales by Type (2024-2029) & (Units)
  • Table 89. China Radiopharmaceutical Injector Sales Share by Type (2018-2023)
  • Table 90. China Radiopharmaceutical Injector Sales Share by Type (2024-2029)
  • Table 91. China Radiopharmaceutical Injector Sales by Application (2018-2023) & (Units)
  • Table 92. China Radiopharmaceutical Injector Sales by Application (2024-2029) & (Units)
  • Table 93. China Radiopharmaceutical Injector Sales Share by Application (2018-2023) & (US$ Million)
  • Table 94. China Radiopharmaceutical Injector Sales Share by Application (2024-2029) & (US$ Million)
  • Table 95. Japan Radiopharmaceutical Injector Sales Quantity by Company (2021-2023) & (Units)
  • Table 96. Japan Radiopharmaceutical Injector Sales Quantity Market Share by Company (2021-2023)
  • Table 97. Japan Radiopharmaceutical Injector Revenue by Company (2021-2023) & (US$ Million)
  • Table 98. Japan Radiopharmaceutical Injector Revenue Market Share by Company (2021-2023)
  • Table 99. Japan Radiopharmaceutical Injector Sales by Type (2018-2023) & (Units)
  • Table 100. Japan Radiopharmaceutical Injector Sales by Type (2024-2029) & (Units)
  • Table 101. Japan Radiopharmaceutical Injector Sales Share by Type (2018-2023)
  • Table 102. Japan Radiopharmaceutical Injector Sales Share by Type (2024-2029)
  • Table 103. Japan Radiopharmaceutical Injector Sales by Application (2018-2023) & (Units)
  • Table 104. Japan Radiopharmaceutical Injector Sales by Application (2024-2029) & (Units)
  • Table 105. Japan Radiopharmaceutical Injector Sales Share by Application (2018-2023) & (US$ Million)
  • Table 106. Japan Radiopharmaceutical Injector Sales Share by Application (2024-2029) & (US$ Million)
  • Table 107. APAC Radiopharmaceutical Injector Sales Quantity by Company (2021-2023) & (Units)
  • Table 108. APAC Radiopharmaceutical Injector Sales Quantity Market Share by Company (2018-2023)
  • Table 109. APAC Radiopharmaceutical Injector Revenue by Company (2021-2023) & (US$ Million)
  • Table 110. APAC Radiopharmaceutical Injector Revenue Market Share by Company (2021-2023)
  • Table 111. APAC Radiopharmaceutical Injector Sales by Type (2018-2023) & (Units)
  • Table 112. APAC Radiopharmaceutical Injector Sales by Type (2024-2029) & (Units)
  • Table 113. APAC Radiopharmaceutical Injector Sales Share by Type (2018-2023)
  • Table 114. APAC Radiopharmaceutical Injector Sales Share by Type (2024-2029)
  • Table 115. APAC Radiopharmaceutical Injector Sales by Application (2018-2023) & (Units)
  • Table 116. APAC Radiopharmaceutical Injector Sales by Application (2024-2029) & (Units)
  • Table 117. APAC Radiopharmaceutical Injector Sales Share by Application (2018-2023) & (US$ Million)
  • Table 118. APAC Radiopharmaceutical Injector Sales Share by Application (2024-2029) & (US$ Million)
  • Table 119. APAC Radiopharmaceutical Injector Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 120. APAC Radiopharmaceutical Injector Revenue by Region (2018-2023) & (US$ Million)
  • Table 121. APAC Radiopharmaceutical Injector Revenue by Region (2024-2029) & (US$ Million)
  • Table 122. APAC Radiopharmaceutical Injector Sales Quantity by Region (2018-2023) & (Units)
  • Table 123. APAC Radiopharmaceutical Injector Sales Quantity by Region (2024-2029) & (Units)
  • Table 124. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Company (2021-2023) & (Units)
  • Table 125. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity Market Share by Company (2021-2023)
  • Table 126. Middle East, Africa and South America Radiopharmaceutical Injector Revenue by Company (2021-2023) & (US$ Million)
  • Table 127. Middle East, Africa and South America Radiopharmaceutical Injector Revenue Market Share by Company (2021-2023)
  • Table 128. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Type (2018-2023) & (Units)
  • Table 129. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Type (2024-2029) & (Units)
  • Table 130. Middle East, Africa and South America Radiopharmaceutical Injector Sales Share by Type (2018-2023)
  • Table 131. Middle East, Africa and South America Radiopharmaceutical Injector Sales Share by Type (2024-2029)
  • Table 132. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Application (2018-2023) & (Units)
  • Table 133. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Application (2024-2029) & (Units)
  • Table 134. Middle East, Africa and South America Radiopharmaceutical Injector Sales Share by Application (2018-2023) & (US$ Million)
  • Table 135. Middle East, Africa and South America Radiopharmaceutical Injector Sales Share by Application (2024-2029) & (US$ Million)
  • Table 136. Middle East, Africa and South America Radiopharmaceutical Injector Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 137. Middle East, Africa and South America Radiopharmaceutical Injector Revenue by Country (2018-2023) & (US$ Million)
  • Table 138. Middle East, Africa and South America Radiopharmaceutical Injector Revenue by Country (2024-2029) & (US$ Million)
  • Table 139. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Country (2018-2023) & (Units)
  • Table 140. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Country (2024-2029) & (Units)
  • Table 141. Medrad, Inc.(Bayer) Company Information
  • Table 142. Medrad, Inc.(Bayer) Description and Overview
  • Table 143. Medrad, Inc.(Bayer) Radiopharmaceutical Injector Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) & (K USD/Unit) and Gross Margin (2021-2023)
  • Table 144. Medrad, Inc.(Bayer) Radiopharmaceutical Injector Products and Services
  • Table 145. UNIVERSAL GIKEN Company Information
  • Table 146. UNIVERSAL GIKEN Description and Overview
  • Table 147. UNIVERSAL GIKEN Radiopharmaceutical Injector Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) & (K USD/Unit) and Gross Margin (2021-2023)
  • Table 148. UNIVERSAL GIKEN Radiopharmaceutical Injector Products and Services
  • Table 149. Comecer Company Information
  • Table 150. Comecer Description and Overview
  • Table 151. Comecer Radiopharmaceutical Injector Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) & (K USD/Unit) and Gross Margin (2021-2023)
  • Table 152. Comecer Radiopharmaceutical Injector Products and Services
  • Table 153. Sumitomo Heavy Industries Company Information
  • Table 154. Sumitomo Heavy Industries Description and Overview
  • Table 155. Sumitomo Heavy Industries Radiopharmaceutical Injector Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) & (K USD/Unit) and Gross Margin (2021-2023)
  • Table 156. Sumitomo Heavy Industries Radiopharmaceutical Injector Products and Services
  • Table 157. Tema Sinergie Company Information
  • Table 158. Tema Sinergie Description and Overview
  • Table 159. Tema Sinergie Radiopharmaceutical Injector Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) & (K USD/Unit) and Gross Margin (2021-2023)
  • Table 160. Tema Sinergie Radiopharmaceutical Injector Products and Services
  • Table 161. Lemer Pax Company Information
  • Table 162. Lemer Pax Description and Overview
  • Table 163. Lemer Pax Radiopharmaceutical Injector Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) & (K USD/Unit) and Gross Margin (2021-2023)
  • Table 164. Lemer Pax Radiopharmaceutical Injector Products and Services
  • Table 165. BQSV Company Information
  • Table 166. BQSV Description and Overview
  • Table 167. BQSV Radiopharmaceutical Injector Sales Quantity (Units), Revenue (US$ Million), Average Selling Price (ASP) & (K USD/Unit) and Gross Margin (2021-2023)
  • Table 168. BQSV Radiopharmaceutical Injector Products and Services
  • Table 169. Raw Materials Key Suppliers Lists
  • Table 170. Radiopharmaceutical Injector Distributors List
  • Table 171. Radiopharmaceutical Injector Customers List
  • Table 172. Research Programs/Design for This Report
  • Table 173. Key Data Information from Secondary Sources
  • Table 174. Key Data Information from Primary Sources
  • Table 175. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

  • Figure 1. Radiopharmaceutical Injector Product Picture
  • Figure 2. Global Radiopharmaceutical Injector Market Share by Type in 2022 & 2029
  • Figure 3. PET Radioactive Drugs Injector Product Picture
  • Figure 4. Major Manufacturers of PET Radioactive Drugs Injector
  • Figure 5. PET and SPECT Radioactive Drugs Injector Product Picture
  • Figure 6. Global Radiopharmaceutical Injector Market Share by Application in 2022 & 2029
  • Figure 7. Hospitals and Clinics
  • Figure 8. R&D Institution
  • Figure 9. Radiopharmaceutical Injector Report Years Considered
  • Figure 10. Global Radiopharmaceutical Injector Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 11. Global Radiopharmaceutical Injector Revenue 2018-2029 (US$ Million)
  • Figure 12. Global Radiopharmaceutical Injector Sales Quantity 2018-2029 (Units)
  • Figure 13. North America Radiopharmaceutical Injector Sales Quantity YoY (2018-2029) & (Units)
  • Figure 14. North America Radiopharmaceutical Injector Revenue YoY (2018-2029) & (US$ Million)
  • Figure 15. Europe Radiopharmaceutical Injector Sales Quantity YoY (2018-2029) & (Units)
  • Figure 16. Europe Radiopharmaceutical Injector Revenue YoY (2018-2029) & (US$ Million)
  • Figure 17. Japan Radiopharmaceutical Injector Sales Quantity YoY (2018-2029) & (Units)
  • Figure 18. Japan Radiopharmaceutical Injector Revenue YoY (2018-2029) & (US$ Million)
  • Figure 19. China Radiopharmaceutical Injector Sales Quantity YoY (2018-2029) & (Units)
  • Figure 20. China Radiopharmaceutical Injector Revenue YoY (2018-2029) & (US$ Million)
  • Figure 21. APAC Radiopharmaceutical Injector Sales Quantity YoY (2018-2029) & (Units)
  • Figure 22. APAC Radiopharmaceutical Injector Revenue YoY (2018-2029) & (US$ Million)
  • Figure 23. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity YoY (2018-2029) & (Units)
  • Figure 24. Middle East, Africa and South America Radiopharmaceutical Injector Revenue YoY (2018-2029) & (US$ Million)
  • Figure 25. Global Radiopharmaceutical Injector Capacity, Production and Utilization (2018-2029) & (Units)
  • Figure 26. Radiopharmaceutical Injector Production Growth Rate in North America (2018-2029) & (Units)
  • Figure 27. Radiopharmaceutical Injector Production Growth Rate in Europe (2018-2029) & (Units)
  • Figure 28. Radiopharmaceutical Injector Production Growth Rate in Japan (2018-2029) & (Units)
  • Figure 29. North America Radiopharmaceutical Injector Revenue Share by Country in 2022
  • Figure 30. North America Radiopharmaceutical Injector Sales Share by Country in 2022
  • Figure 31. United States Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 32. Canada Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 33. Mexico Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 34. Europe Radiopharmaceutical Injector Revenue Share by Country in 2022
  • Figure 35. Europe Radiopharmaceutical Injector Sales Quantity Share by Country in 2022
  • Figure 36. Germany Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 37. France Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 38. U.K. Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 39. Italy Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 40. Benelux Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 41. APAC Radiopharmaceutical Injector Revenue Share by Region in 2022
  • Figure 42. South Korea Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 43. Southeast Asia Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 44. India Radiopharmaceutical Injector Revenue (2018-2029) & (US$ Million)
  • Figure 45. Middle East, Africa and South America Radiopharmaceutical Injector Revenue Share by Country in 2022
  • Figure 46. Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity Share by Country in 2022
  • Figure 47. Radiopharmaceutical Injector Value Chain
  • Figure 48. Radiopharmaceutical Injector Production Process
  • Figure 49. Channels of Distribution (Direct Vs Distribution)
  • Figure 50. Distributors Profiles
  • Figure 51. Bottom-up and Top-down Approaches for This Report
  • Figure 52. Data Triangulation
  • Figure 53. Key Executives Interviewed
目次

The Radiopharmaceutical Injector market was valued at US$ 27.21 million in 2022 and is projected to reach US$ 46.18 million by 2029, at a CAGR of 7.35% during the forecast period (2023-2029).

The global key manufacturers of Radiopharmaceutical Injector include: Medrad, Inc.(Bayer), UNIVERSAL GIKEN, Comecer, Sumitomo Heavy Industries, Tema Sinergie, Lemer Pax, BQSV, and etc. In 2022, the global top five players hold a share approximately 84.23% in sales volume, and in term of revenue of Radiopharmaceutical Injector, the top five companies hold a share nearly 84.93%.

In terms of production side, this report researches the Radiopharmaceutical Injector capacity, production, growth rate, market share by manufacturers and regional level and country level, from 2018 to 2023, and forecast to 2029.

In terms of sales (consumption) side, this report focuses on the sales of Radiopharmaceutical Injector by regions (Countries), company, by Type and by Application. from 2018 to 2023 and forecast to 2029.

The global Radiopharmaceutical Injector market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Radiopharmaceutical Injector market. These figures have been provided in terms of both revenue and volume for the period 2018-2029. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

By Company

  • Medrad, Inc.(Bayer)
  • UNIVERSAL GIKEN
  • Comecer
  • Sumitomo Heavy Industries
  • Tema Sinergie
  • Lemer Pax
  • BQSV

Segment by Type

  • PET Radioactive Drugs Injector
  • PET and SPECT Radioactive Drugs Injector

Segment by Application

  • Hospitals and Clinics
  • R&D Institution

Production by Region

  • North America
  • Europe
  • Japan

Sales by Region

  • North America
  • United States
  • Canada
  • Mexico
  • China
  • Japan
  • APAC (excluding China and Japan)
  • South Korea
  • Southeast Asia
  • India
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Benelux
  • Middle East & Africa, South America

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Radiopharmaceutical Injector in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Radiopharmaceutical Injector production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
  • Chapter 4: Detailed analysis of Radiopharmaceutical Injector manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by company, by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: Europe by company, by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: China by company, by Type, and by Application, sales, and revenue for each segment.
  • Chapter 10: APAC (excluding China) by company, by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East, Africa, and South America by company, by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiopharmaceutical Injector sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 15: The main points and conclusions of the report.

Table of Contents

1 Report Overview

  • 1.1 Radiopharmaceutical Injector Definition
  • 1.2 Market by Type
    • 1.2.1 Global Radiopharmaceutical Injector Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 PET Radioactive Drugs Injector
    • 1.2.3 PET and SPECT Radioactive Drugs Injector
  • 1.3 Market by Application
    • 1.3.1 Global Radiopharmaceutical Injector Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Hospitals and Clinics
    • 1.3.3 R&D Institution
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Radiopharmaceutical Injector Sales

  • 2.1 Global Radiopharmaceutical Injector Revenue Estimates and Forecasts 2018-2029
  • 2.2 Global Radiopharmaceutical Injector Revenue by Region: 2018 VS 2022 VS 2029
  • 2.3 Global Radiopharmaceutical Injector Revenue by Region
    • 2.3.1 Global Radiopharmaceutical Injector Revenue by Region (2018-2023)
    • 2.3.2 Global Radiopharmaceutical Injector Revenue by Region (2024-2029)
  • 2.4 Global Radiopharmaceutical Injector Sales Quantity Estimates and Forecasts 2018-2029
  • 2.5 Global Radiopharmaceutical Injector Sales Quantity by Region: 2018 VS 2022 VS 2029
  • 2.6 Global Radiopharmaceutical Injector Sales Quantity by Region
    • 2.6.1 Global Radiopharmaceutical Injector Sales Quantity by Region (2018-2023)
    • 2.6.2 Global Radiopharmaceutical Injector Sales Quantity by Region (2024-2029)
  • 2.7 North America
  • 2.8 Europe
  • 2.9 Japan
  • 2.10 China
  • 2.11 APAC (excluding China and Japan)
  • 2.12 Middle East, Africa and South America

3 Global Production (Based on Production Site)

  • 3.1 Global Radiopharmaceutical Injector Production Capacity (2018-2029)
  • 3.2 Global Radiopharmaceutical Injector Production by Region: 2018 VS 2022 VS 2029
  • 3.3 Global Radiopharmaceutical Injector Production by Region
    • 3.3.1 Global Radiopharmaceutical Injector Historic Production by Region (2018-2023)
    • 3.3.2 Global Radiopharmaceutical Injector Forecasted Production by Region (2024-2029)
    • 3.3.3 North America
    • 3.3.4 Europe
    • 3.3.5 Japan

4 Competition by Manufacturers

  • 4.1 Global Radiopharmaceutical Injector Sales Quantity by Manufacturers
    • 4.1.1 Global Radiopharmaceutical Injector Sales Quantity by Manufacturers (2021-2023)
    • 4.1.2 Global Radiopharmaceutical Injector Sales Quantity Share by Manufacturers (2021-2023)
  • 4.2 Global Radiopharmaceutical Injector Revenue by Manufacturers
    • 4.2.1 Global Radiopharmaceutical Injector Revenue by Manufacturers (2021-2023)
    • 4.2.2 Global Radiopharmaceutical Injector Revenue Share by Manufacturers (2021-2023)
  • 4.3 Global Radiopharmaceutical Injector Sales Price by Manufacturers
  • 4.4 Analysis of Competitive Landscape
    • 4.4.1 Manufacturers Market Concentration Ratio (CR5)
    • 4.4.2 Global Radiopharmaceutical Injector Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 4.5 Global Key Manufacturers of Radiopharmaceutical Injector, Major Market Areas and Headquarters
  • 4.6 Global Key Manufacturers of Radiopharmaceutical Injector, Product Offered
  • 4.7 Global Key Manufacturers of Radiopharmaceutical Injector, Date of Enter into This Industry

5 Estimates and Forecasts by Type

  • 5.1 Global Radiopharmaceutical Injector Sales Quantity by Type
    • 5.1.1 Global Radiopharmaceutical Injector Historical Sales Quantity by Type (2018-2023)
    • 5.1.2 Global Radiopharmaceutical Injector Forecasted Sales Quantity by Type (2024-2029)
    • 5.1.3 Global Radiopharmaceutical Injector Sales Quantity Market Share by Type (2018-2029)
  • 5.2 Global Radiopharmaceutical Injector Revenue by Type
    • 5.2.1 Global Radiopharmaceutical Injector Historical Revenue by Type (2018-2023)
    • 5.2.2 Global Radiopharmaceutical Injector Forecasted Revenue by Type (2024-2029)
    • 5.2.3 Global Radiopharmaceutical Injector Revenue Market Share by Type (2018-2029)
  • 5.3 Global Radiopharmaceutical Injector Price by Type
    • 5.3.1 Global Radiopharmaceutical Injector Price by Type (2018-2023)
    • 5.3.2 Global Radiopharmaceutical Injector Price Forecast by Type (2024-2029)

6 Market Size by Application

  • 6.1 Global Radiopharmaceutical Injector Sales Quantity by Application
    • 6.1.1 Global Radiopharmaceutical Injector Historical Sales Quantity by Application (2018-2023)
    • 6.1.2 Global Radiopharmaceutical Injector Forecasted Sales Quantity by Application (2024-2029)
    • 6.1.3 Global Radiopharmaceutical Injector Sales Quantity Market Share by Application (2018-2029)
  • 6.2 Global Radiopharmaceutical Injector Revenue by Application
    • 6.2.1 Global Radiopharmaceutical Injector Historical Revenue by Application (2018-2023)
    • 6.2.2 Global Radiopharmaceutical Injector Forecasted Revenue by Application (2024-2029)
    • 6.2.3 Global Radiopharmaceutical Injector Revenue Market Share by Application (2018-2029)
  • 6.3 Global Radiopharmaceutical Injector Price by Application
    • 6.3.1 Global Radiopharmaceutical Injector Price by Application (2018-2023)
    • 6.3.2 Global Radiopharmaceutical Injector Price Forecast by Application (2024-2029)

7 North America

  • 7.1 North America Radiopharmaceutical Injector Sales by Company
    • 7.1.1 North America Radiopharmaceutical Injector Sales Quantity by Company (2021-2023)
    • 7.1.2 North America Radiopharmaceutical Injector Revenue by Company (2021-2023)
  • 7.2 North America Radiopharmaceutical Injector Market Size by Type
    • 7.2.1 North America Radiopharmaceutical Injector Sales Quantity by Type (2018-2029)
    • 7.2.2 North America Radiopharmaceutical Injector Sales Share by Type (2018-2029)
  • 7.3 North America Radiopharmaceutical Injector Market Size by Application
    • 7.3.1 North America Radiopharmaceutical Injector Sales Quantity by Application (2018-2029)
    • 7.3.2 North America Radiopharmaceutical Injector Sales Share by Application (2018-2029)
  • 7.4 North America Radiopharmaceutical Injector Market Size by Country
    • 7.4.1 North America Radiopharmaceutical Injector Revenue by Country: 2018 VS 2022 VS 2029
    • 7.4.2 North America Radiopharmaceutical Injector Revenue by Country (2018-2029)
    • 7.4.3 North America Radiopharmaceutical Injector Sales Quantity by Country (2018-2029)
    • 7.4.4 United States
    • 7.4.5 Canada
    • 7.4.6 Mexico

8 Europe

  • 8.1 Europe Radiopharmaceutical Injector Sales by Company
    • 8.1.1 Europe Radiopharmaceutical Injector Sales Quantity by Company (2021-2023)
    • 8.1.2 Europe Radiopharmaceutical Injector Revenue by Company (2021-2023)
  • 8.2 Europe Radiopharmaceutical Injector Market Size by Type
    • 8.2.1 Europe Radiopharmaceutical Injector Sales by Type (2018-2029)
    • 8.2.2 Europe Radiopharmaceutical Injector Sales Share by Type (2018-2029)
  • 8.3 Europe Radiopharmaceutical Injector Market Size by Application
    • 8.3.1 Europe Radiopharmaceutical Injector Sales Quantity by Application (2018-2029)
    • 8.3.2 Europe Radiopharmaceutical Injector Sales Share by Application (2018-2029)
  • 8.4 Europe Radiopharmaceutical Injector Market Size by Country
    • 8.4.1 Europe Radiopharmaceutical Injector Revenue by Country: 2018 VS 2022 VS 2029
    • 8.4.2 Europe Radiopharmaceutical Injector Revenue by Country (2018-2029)
    • 8.4.3 Europe Radiopharmaceutical Injector Sales Quantity by Country (2018-2029)
    • 8.4.4 Germany
    • 8.4.5 France
    • 8.4.6 U.K.
    • 8.4.7 Italy
    • 8.4.8 Benelux

9 China

  • 9.1 China Radiopharmaceutical Injector Sales by Company
    • 9.1.1 China Radiopharmaceutical Injector Sales Quantity by Company (2021-2023)
    • 9.1.2 China Radiopharmaceutical Injector Revenue by Company (2021-2023)
  • 9.2 China Radiopharmaceutical Injector Market Size by Type
    • 9.2.1 China Radiopharmaceutical Injector Sales by Type (2018-2029)
    • 9.2.2 China Radiopharmaceutical Injector Sales Share by Type (2018-2029)
  • 9.3 China Radiopharmaceutical Injector Market Size by Application
    • 9.3.1 China Radiopharmaceutical Injector Sales by Application (2018-2029)
    • 9.3.2 China Radiopharmaceutical Injector Sales Share by Application (2018-2029)

10 Japan

  • 10.1 Japan Radiopharmaceutical Injector Sales by Company
    • 10.1.1 Japan Radiopharmaceutical Injector Sales Quantity by Company (2021-2023)
    • 10.1.2 Japan Radiopharmaceutical Injector Revenue by Company (2021-2023)
  • 10.2 Japan Radiopharmaceutical Injector Market Size by Type
    • 10.2.1 Japan Radiopharmaceutical Injector Sales by Type (2018-2029)
    • 10.2.2 Japan Radiopharmaceutical Injector Sales Share by Type (2018-2029)
  • 10.3 Japan Radiopharmaceutical Injector Market Size by Application
    • 10.3.1 Japan Radiopharmaceutical Injector Sales by Application (2018-2029)
    • 10.3.2 Japan Radiopharmaceutical Injector Sales Share by Application (2018-2029)

11 APAC (excluding China and Japan)

  • 11.1 APAC Radiopharmaceutical Injector Sales by Company
    • 11.1.1 APAC Radiopharmaceutical Injector Sales Quantity by Company (2021-2023)
    • 11.1.2 APAC Radiopharmaceutical Injector Revenue by Company (2021-2023)
  • 11.2 APAC Radiopharmaceutical Injector Market Size by Type
    • 11.2.1 APAC Radiopharmaceutical Injector Sales by Type (2018-2029)
    • 11.2.2 APAC Radiopharmaceutical Injector Sales Share by Type (2018-2029)
  • 11.3 APAC Radiopharmaceutical Injector Market Size by Application
    • 11.3.1 APAC Radiopharmaceutical Injector Sales by Application (2018-2029)
    • 11.3.2 APAC Radiopharmaceutical Injector Sales Share by Application (2018-2029)
  • 11.4 APAC Radiopharmaceutical Injector Market Size by Region
    • 11.4.1 APAC Radiopharmaceutical Injector Revenue by Region: 2018 VS 2022 VS 2029
    • 11.4.2 APAC Radiopharmaceutical Injector Revenue by Region (2018-2029)
    • 11.4.3 APAC Radiopharmaceutical Injector Sales Quantity by Region (2018-2029)
    • 11.4.4 South Korea
    • 11.4.5 Southeast Asia
    • 11.4.6 India

12 Middle East, Africa and South America

  • 12.1 Middle East, Africa and South America Radiopharmaceutical Injector Sales by Company
    • 12.1.1 Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Company (2021-2023)
    • 12.1.2 Middle East, Africa and South America Radiopharmaceutical Injector Revenue by Company (2021-2023)
  • 12.2 Middle East, Africa and South America Radiopharmaceutical Injector Market Size by Type
    • 12.2.1 Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Type (2018-2029)
    • 12.2.2 Middle East, Africa and South America Radiopharmaceutical Injector Sales Share by Type (2018-2029)
  • 12.3 Middle East, Africa and South America Radiopharmaceutical Injector Market Size by Application
    • 12.3.1 Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Application (2018-2029)
    • 12.3.2 Middle East, Africa and South America Radiopharmaceutical Injector Sales Share by Application (2018-2029)
  • 12.4 Middle East, Africa and South America Radiopharmaceutical Injector Market Size by Country
    • 12.4.1 Middle East, Africa and South America Radiopharmaceutical Injector Revenue by Country: 2018 VS 2022 VS 2029
    • 12.4.2 Middle East, Africa and South America Radiopharmaceutical Injector Revenue by Country (2018-2029)
    • 12.4.3 Middle East, Africa and South America Radiopharmaceutical Injector Sales Quantity by Country (2018-2029)

13 Company Profiles

  • 13.1 Medrad, Inc.(Bayer)
    • 13.1.1 Medrad, Inc.(Bayer) Company Information
    • 13.1.2 Medrad, Inc.(Bayer) Overview
    • 13.1.3 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
    • 13.1.4 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Products and Services
  • 13.2 UNIVERSAL GIKEN
    • 13.2.1 UNIVERSAL GIKEN Company Information
    • 13.2.2 UNIVERSAL GIKEN Overview
    • 13.2.3 UNIVERSAL GIKEN Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
    • 13.2.4 UNIVERSAL GIKEN Radiopharmaceutical Injector Products and Services
  • 13.3 Comecer
    • 13.3.1 Comecer Company Information
    • 13.3.2 Comecer Overview
    • 13.3.3 Comecer Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
    • 13.3.4 Comecer Radiopharmaceutical Injector Products and Services
  • 13.4 Sumitomo Heavy Industries
    • 13.4.1 Sumitomo Heavy Industries Company Information
    • 13.4.2 Sumitomo Heavy Industries Overview
    • 13.4.3 Sumitomo Heavy Industries Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
    • 13.4.4 Sumitomo Heavy Industries Radiopharmaceutical Injector Products and Services
  • 13.5 Tema Sinergie
    • 13.5.1 Tema Sinergie Company Information
    • 13.5.2 Tema Sinergie Overview
    • 13.5.3 Tema Sinergie Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
    • 13.5.4 Tema Sinergie Radiopharmaceutical Injector Products and Services
  • 13.6 Lemer Pax
    • 13.6.1 Lemer Pax Company Information
    • 13.6.2 Lemer Pax Overview
    • 13.6.3 Lemer Pax Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
    • 13.6.4 Lemer Pax Radiopharmaceutical Injector Products and Services
  • 13.7 BQSV
    • 13.7.1 BQSV Company Information
    • 13.7.2 BQSV Overview
    • 13.7.3 BQSV Radiopharmaceutical Injector Sales Quantity, Revenue, Price and Gross Margin (2021-2023)
    • 13.7.4 BQSV Radiopharmaceutical Injector Products and Services

14 Value Chain and Sales Channels Analysis

  • 14.1 Radiopharmaceutical Injector Value Chain Analysis
  • 14.2 Radiopharmaceutical Injector Key Raw Materials
    • 14.2.1 Key Raw Materials
    • 14.2.2 Raw Materials Key Suppliers
  • 14.3 Radiopharmaceutical Injector Production Mode & Process
  • 14.4 Radiopharmaceutical Injector Sales and Marketing
    • 14.4.1 Radiopharmaceutical Injector Sales Channels
    • 14.4.2 Radiopharmaceutical Injector Distributors
  • 14.5 Radiopharmaceutical Injector Customers

15 Radiopharmaceutical Injector Market Dynamics

  • 15.1 Radiopharmaceutical Injector Industry Trends
  • 15.2 Radiopharmaceutical Injector Market Drivers
  • 15.3 Radiopharmaceutical Injector Market Challenges
  • 15.4 Radiopharmaceutical Injector Market Restraints

16 Key Findings

17 Appendix

  • 17.1 Research Methodology
    • 17.1.1 Methodology/Research Approach
    • 17.1.2 Data Source
  • 17.2 Author Details
  • 17.3 Disclaimer